跳至主要内容
临床试验/NCT02570776
NCT02570776Unknown不适用

Prevalence of Helicobacter Pylori Infection in Dyspeptic Adults and Validation of C14 Urea Breath Test (UBT) as a Diagnostic Tool for Helicobacter Pylori Infection in Pakistani Population

National Institute of Liver & GI Diseases, Pakistan1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Prevalence of H pylori infection in Pakistani polulation

研究概览

简要总结

The prevalence of H. pylori infection in Pakistan is unknown and investigators want to assess it in dyspeptic patients utilizing UBT. At the same time investigators want to validate UBT sensitivity and specificity in Pakistani patients

详细描述

The non-invasive methods for the diagnosis of Hp are the Urea Breath Test (UBT) and serological tests. The serological tests includes ELISA test in serum for Hp antibody and in stool for Hp antigen. Serum ELISA Hp antibody is not sensitive for showing active infection and the titres do not decrease even after successful eradication. Serology test cannot be used for those who have previously been treated for Hp, as the decline in titre of Hp antibodies is too slow to be of practical use. The stool Hp antigen detection test is more sensitive and specific as it detects bacterial antigens which will only be positive in the presence of Hp. However, it is cumbersome to collect stool and laboratory services are required. The C14 Urea Breath Test (UBT) is an office based test with sensitivity and specificity comparable to that of the stool antigen test. The diagnostic validity of these tests depends on the prevalence of H pylori infection. A higher prevalence would be associated with higher sensitivity and lower specificity. The safety profile of the urea breath test is very favourable, and no major side effects are associated with it. The aims of this study are to estimate H pylori prevalence in Pakistan among the adult dyspeptic population and to validate the sensitivity and specificity UBT in our population

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects with dyspeptic symptoms (B1 Criteria of FD)
  • Subject who has not been treated for H pylori eradication in the past
  • Age above 18 years
  • No Alarm symptoms of :
  • Gastrointestinal Bleeding
  • Early satiety
  • Unexplained weight loss
  • Progressive dysphagia
  • Odynophagia
  • Recurrent vomiting
  • Family history of GI malignancy
  • Previous GI malignancy

排除标准

  • Pregnant females
  • Use of NSAIDs
  • Use of anti- secretory agent (H2 blockers) and proton pump inhibitors in previous 4 weeks
  • Use of anti- microbial agents (Clarithromycin, Metronidazole, Amoxacillin, quinalones) or bismuth in last 4 weeks
  • .Gastric and/or duodenal erosions or ulcers, polyps or malignancy if noted on endoscopy will be excluded.
  • Patients with predominant symptoms or gastro esophageal reflux disease (GERD) or Endoscopic evidence of esophagitis.
  • Patients with abnormal upper abdominal ultrasound.

结局指标

主要结局

Prevalence of H pylori infection in Pakistani polulation

时间窗: 1 day

Prevalence of H pylori will be assessed by UBT \& confirmed with histopathology as gold standard \& sensitivity \& specificity will be calculated.

次要结局

  • Sensivity & specificity of Heliprobe (C14 UBT system) in local population(1 day)

研究者

发起方
National Institute of Liver & GI Diseases, Pakistan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Zahid Azam

Professor Medicine & Gastroenterology

National Institute of Liver & GI Diseases, Pakistan

研究点 (1)

Loading locations...

相似试验